by CARDIOSINTESIS PODCAST
Cardiosíntesis es un programa destinado a la divulgación científica de temas cardiológicos y de ciencias afines a la cardiología como parte del proyecto Cardiociencias del Instituto Nacional de Cardiología Ignacio Chávez. Visita la página www.cardiociencias.com para consultar más contenido educativo.
Language
🇪🇸
Publishing Since
3/1/2021
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
April 1, 2026
En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este tercer día en el ACC 2026 de Nueva Orleans. 1. Redo-Surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial 2. The Heartline Experience: Achieving Long-Term Participant Engagement in Digital Health Technology Trials 3. Effect Of Anti-fibrotic Therapy On Regression Of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) In Aortic Stenosis Patients With High Fibrotic Burden: The Reduce-MFA DZHK 25-trial
March 31, 2026
En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este tercer día en el ACC 2026 de Nueva Orleans. 1. SirPAD: Sirolimus-Coated vs. Uncoated Balloons in Angioplasty For Infrainguinal Artery Disease 2. Intravascular Ultrasound–Guided or Angiography-Guided Complex High-Risk PCI 3. Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention In Unprotected Left Main Coronary Artery Disease - The Optimal Trial 4. Artificial Intelligence Based Screening For Structural Heart Disease Using An ECG: Results From The PREVUE-VALVE Study 5. Digoxin in Rheumatic Heart Disease: A Multi-Center, Randomized, Double Blind, Placebo-controlled Trial 6. Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction
March 30, 2026
En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este segundo día en el ACC 2026 de Nueva Orleans. 1. Redo-Surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial 2. Transcatheter Aortic Valve Implantation Without Routine Percutaneous Coronary Intervention: A Randomized Controlled Trial 3. Protect The Head To Head Trial: Randomized Comparison of Emboliner Embolic Protection Catheter Vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement 4. Two-Year Outcomes After Transcatheter Tricuspid Repair Without Cross-over in the Randomized Tri-fr Trial 5. Spironolactone in the Treatment of Heart Failure (SPIRIT-HF)
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
Cardiosíntesis es un programa destinado a la divulgación científica de temas cardiológicos y de ciencias afines a la cardiología como parte del proyecto Cardiociencias del Instituto Nacional de Cardiología Ignacio Chávez.
Visita la página www.cardiociencias.com para consultar más contenido educativo.
This podcast updates bi-weekly.
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
No, this podcast does not typically feature guests.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.